Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (2)
  • 2023 (3)
  • 2022 (7)
  • 2021 (9)
  • 2019 (4)

Subject

  • Prescription Drugs (5)
  • Outreach/Drug Prevention (2)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Synthetic drugs (2)
  • Diversion Division (1)
  • Drug Trafficking (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Seizures (Drugs/Property) (1)
  • Task Forces/Task Force Officers (1)

Drug Name

  • Fentanyl (267)
  • Methamphetamine (256)
  • Cocaine (246)
  • Heroin (151)
  • Oxycodone (58)
  • Marijuana (Cannabis) (52)
  • Opioids (52)
  • Synthetic Opioids (28)
  • Amphetamines (8)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • Hydromorphone (4)
  • K2/Spice (3)
  • Methadone (3)
  • Ketamine (2)
  • Steroids (2)
  • LSD (1)
  • Marijuana Concentrates (1)
  • Benzodiazepines (9)
  • Synthetic Bath Salts or Designer Cathinones (0)

Field Division

  • St. Louis (3)
  • Washington, DC (3)
  • Atlanta (2)
  • Houston (1)
Clear All Results
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

November 19, 2021
Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
November 19, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
PRESS RELEASE

DEA Washington Chief Issues Public Safety Alert: Dangerous Increase in Fake Rx Pills Containing Fentanyl

September 27, 2021
Washington, D.C. – Today, Jarod Forget, Special Agent in Charge of the DEA Washington Division issued a Public Safety Alert warning Maryland, Virginia, and Washington, D.C. residents of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl in our area. This DEA Public Safety Alert...
September 27, 2021
PRESS RELEASE

Southeast Missouri Health Organization Pays $1.6 Million Settlement for Invalid Prescriptions

September 01, 2021
St. Louis, Mo. - Saint Francis Medical Center of Southeast Missouri has agreed to pay more than $1.6 million to settle a civil suit by the United States, resolving claims under the Controlled Substances Act. The U.S. government alleged that Saint Francis employed a Farmington, Missouri, physician, Brett Dickinson, who...
September 01, 2021
PRESS RELEASE

Grand Jury indicts St. Charles Woman for Selling Prescriptions

August 19, 2021
ST. LOUIS – A federal grand jury issued a 25-count indictment Aug. 18 against Katie Diana Rooney charging her with health-care fraud and controlled substance offenses. At the time Rooney allegedly committed these offenses, she was a resident of St. Charles, Missouri. The indictment alleges that through fraud and deceit...
August 19, 2021
PRESS RELEASE

Doctor Indicted for Illegally Prescribing Controlled Substances

August 19, 2021
ST. LOUIS – A federal grand jury issued a 13-count indictment Aug. 18 against Matthew Steven Miller, D.O., charging him with illegally prescribing controlled substances and other related offenses. At the time Miller allegedly committed these offenses, he was licensed to practice medicine in Missouri, Michigan, and New Jersey. The...
August 19, 2021
PRESS RELEASE

DEA Washington Launches New Conference Series to Work with Healthcare Professionals & Help End the Overdose Crisis

April 22, 2021
The DEA Washington Division, an agency currently working to expand partnerships to offer targeted, full-scope solutions for the drug problems in Maryland, Washington DC, and Virginia, today introduced a new webinar series, “Empowering DMV Healthcare Professionals.” The idea for this unique concept was crystalized during the pandemic, when overdose rates...
April 22, 2021
PRESS RELEASE

Second of Two Defendants Sentenced in Scheme to Steal, Sell Drugs from Nursing Home Patients

April 19, 2021
BRUNSWICK, GA - Two former employees of a nursing and personal care facility have been sentenced after admitting to a scheme in which they stole and resold prescription drugs. Rochella Ellison, 48, of Townsend, Ga., and Nadia Gibson, 38, of Jacksonville, Fla., each were sentenced to probation after pleading guilty...
April 19, 2021
PRESS RELEASE

Owner of Savannah-Area Clinic Charged for Role in Providing Access to Notorious ‘Pill Mill’ Doctor

February 09, 2021
SAVANNAH, GA - A Garden City, Ga., clinic owner and CEO has been indicted for operating a clinic that provided a base from which a notorious “pill mill” doctor dispensed massive amounts of controlled substances. In a five-count indictment returned by a U.S. District Court grand jury, Jamesetta Whipple-Duncan, 58...
February 09, 2021
Showing 1 - 9 of 9 results
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster